Prof. de Meirleir en kollega's hebben de stoelgang van ME(CVS)-patiënten onderzocht.
Hun konklusie luidt:
In de ontlasting van ME(CVS)-patiënten komen beduidend meer
gram-positieve anaerobe, D-melkzuur producerende bakteria voor.
De symptomen van D-melkzuur vergiftiging lijken deels op die van ME(CVS):
klik hier.
Deze bevinding sluit aan bij de excessieve H2S-produktie in de darmen (klik hier).
Die theorie van prof. de Meirleir over overbegroeiing van de darmen en de H2S-theorie
is terug te vinden in het verslag van de Invest in ME-konferentie: klik hier.
Increased D-Lactic Acid Intestinal Bacteria in Patients with Chronic Fatigue Syndrome
In Vivo July 2009 23:621-628.
Sheedy JR, Wettenhall RE, Scanlon D, Gooley PR, Lewis DP, McGregor N, Stapleton DI, Butt HL, De Meirleir KL.
Patients with chronic fatigue syndrome (CFS)
are affected by
symptoms of
cognitive dysfunction and
neurological impairment,
the cause of which has yet to be elucidated.
However,
these symptoms
are strikingly similar to
those of patients
presented with D-lactic acidosis.
A significant increase of
Gram positive facultative anaerobic faecal microorganisms
in 108 CFS patients
as compared to 177 control subjects (p<0.01)
is presented in this report.
The viable count of
D-lactic acid producing
Enterococcus and
Streptococcus spp.
in the faecal samples
from the CFS group
(3.5×107 cfu/L and 9.8×107 cfu/L respectively)
were significantly higher than
those for the control group
(5.0×106 cfu/L and 8.9×104 cfu/L respectively).
Analysis of exometabolic profiles of
Enterococcus faecalis and
Streptococcus sanguinis,
representatives of
Enterococcus and
Streptococcus spp. respectively,
by NMR and HPLC
showed that
these organisms
produced significantly more
lactic acid (p<0.01)
from 13C-labeled glucose,
than the Gram negative Escherichia coli.
Further,
both
E. faecalis and
S. sanguinis
secrete more D-lactic acid
than E. coli.
This study suggests
a probable link
between intestinal colonization of
Gram positive facultative anaerobic D-lactic acid bacteria and
symptom expressions
in a subgroup of patients with CFS.
Given the fact that
this might explain
not only neurocognitive dysfunction in CFS patients
but also mitochondrial dysfunction,
these findings may have important clinical implications.
http://iv.iiarjournals.org/content/23/4/621.abstract
Met dank aan Jan van Roijen (Help ME Circle) en Rubia.
|